Browsing Category
Health
Research shows that weight-loss medications can reduce cancer risk by up to a fifth.
Doctors said that weight-loss drugs are a powerful weapon in the fight against cancer. They have "enormous" potential to shrink tumours and prevent new cases.
Blockbuster injections such as Wegovy have revolutionised the treatment of…
Entrepreneurs who believe AI can save the NHS
Another week of fascinating developments in the field of artificial intelligence. OpenAI, based in San Francisco, unveiled a new model that can translate languages in real-time and tutor children in algebra.
Sundar Pichai, the Google…
Ozempic is a weight loss drug that can also be used to treat dementia and addiction.
The drug has been in the news for a number of years, firstly as a treatment for type 2 diabetics and then as an aid to weight loss. Semaglutide, also known as Ozempic and Wegovy, could have benefits for a variety of medical conditions…
Novo Nordisk will test the effects of weight-loss drugs on alcohol consumption and liver disease.
Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis.
The Danish pharmaceutical company started recruiting for…
Retatrutide, a new drug that outperforms Ozempic, helps people to lose a quarter of their weight
The new weight-loss jab outperforms its competitors, including Ozempic. It helps obese patients lose four stone in under a year.
Retatrutide acts on three receptors in the mind, "turbocharging", calorie burn while making people full.…
AstraZeneca pulls Covid vaccine months after admitting to rare side effects
The company says the decision was made purely for commercial reasons, as alternatives to jab have been developed.
The Oxford-AstraZeneca Covid vaccination is being withdrawn from the market worldwide. This comes months after the…
Think-tank warns that obesity and low productivity are linked in the UK
According to a new report, millions of obese people cannot work or are less efficient. This condition may explain the record-high rates of economic inactivity in the UK due to illness.
Think-tank Institute for Public Policy Research is…
Long-term illness is causing a record number of people to be out of work
The number of workers who are out of work due to long-term illness has risen to a new record of over 2.8 million.
Since the Covid pandemic began, economic inactivity (when an individual is not working and not seeking a job) has steadily…
The rise in prostate cancer has prompted calls for a change in testing
Scientists have called on countries to overhaul prostate cancer testing in order to focus more attention on vulnerable groups. New research predicts that global deaths due this disease will nearly double within 20 years.
According to a…
Indivior’s US moves gets closer as major investors will not oppose the move
Indivior's top shareholder -- one of the largest institutional investors in the City -- is unlikely oppose its plans to move to the United States.
Indivior, a company that specializes in treating substance abuse disorders and serious…
Novo-Nordisk gives me a boost with a double dose of power.
Most people prefer to take a pill rather than inject themselves with medication when they are sick. This simple fact helped Novo-Nordisk, (stock ticker:NOVO), to become the third-most valuable holding in my “forever fund” after renewed hope…
AstraZeneca purchases rare diseases group in order to boost drug pipeline
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its efforts to boost the pipeline of drugs.
AstraZeneca agreed to…
AstraZeneca builds £450m vaccine center in Liverpool as boost for UK
AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of AstraZeneca said that Rishi Sunak’s policies discouraged…
Smith & Nephew Reports Healthy Revival
Smith & Nephew's revival is taking hold, according to the chief executive of the FTSE 100 medical products maker after it posted better-than expected fourth-quarter financial results.
The underlying revenue increased by 6.4 percent…
Indivior to move primary listing from London to US
The latest blow to London as a financial hub is the plan to relocate the primary listing of one of the largest anti-opioid companies in the world to the United States.
Indivior, a FTSE 250 pharmaceuticals firm that specializes in…
GSK’s blockbuster hepatitis treatment is approved by American regulators
One of Britain's largest drug companies secured a fast track review of a potentially blockbuster treatment of chronic hepatitis B.
GSK announced that the US Food and Drug Administration has granted bepirovirsen an expedited approval…
Redx Pharma is aiming for New York listing
Redx Pharma has decided to list in New York because it wants to tap into a wider and more specialized pool of investors.
The latest blow for the City is that the London-listed Biotechnology Company, which has been through a turbulent…
Alzheimer’s disease was transmitted between humans using a now-banned technique, study finds
Scientists shed new light on the spread of Alzheimer's disease in the brain, and discovered the first evidence that it can be transmitted between people via the now-banned growth hormone for humans.
The study was published on Monday in…